Download a printable agenda

13:00 – 13:20Registration
13:20 – 13:30Welcome
Miranda Weston-Smith, Founder, BioBeat
Sally Ann Forsyth, CEO, Stevenage BioScience Catalyst
Victoria Higgins, Senior Director, Research & Development, GSK
13:30 – 14:00Keynote
Emma Walmsley, CEO, GSK
C&GT at GSK: Innovation and Value Creation
14:00 – 15:00Panel 1: Leveraging science
This panel lives the translational journey from scientific innovation to scale up of C&GT and asks where are the biggest opportunities?
On the panel:
Tamsin Berry, Director, Office of Life Sciences, Department for Business, Energy and Industrial Strategy
Aisha Hasan, Clinical Development Head, Cell and Gene Therapy Oncology, GSK
Giovanna Lombardi, Professor of Human Transplant Immunology, King’s College London
Emma Morris, Professor of Clinical Cell and Gene Therapy, UCL Institute of Immunity and Transplantation (Chair)
Sophie Papa, Clinical Reader and Honorary Consultant Medical Oncologist, Guy’s Cancer at Guy’s and St Thomas’ NHS Trust
Jane Robertson, CMO, Achilles Therapeutics
15:00 – 15:30Break
15:30 – 16:30 Panel 2: Optimising value
This panel unwraps the drivers for value in C&GT, from commercial return to impact on health, and asks how best to balance needs?
On the panel:
Karen Hodgkin, COO, CellMedica (Chair)
Jeanette Kusel, Director, NICE Scientific Advice
Angela Osborne, MD, eXmoor Pharma
Anna Outhwaite, Head of ATTC Network Coordination, Cell and Gene Therapy Catapult
Tara Raveendran, Head of Life Sciences Research, Shore Capital
Jane Whitrow, VP Business Operations, Freeline Therapeutics
16:30 – 16:35Close and thanks
16:35 – 18:00Refreshments & Networking